Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Mouse (Murine) PDK1 Anticorps:
anti-Human PDK1 Anticorps:
Vous arrivez à notre recherche pré-filtrée.
Here, the authors show that loss of Fxn (Montrer FXN Anticorps) in the nervous system in mice also activates an iron/sphingolipid/PDK1 (Montrer PDPK1 Anticorps)/Mef2 (Montrer MEF2C Anticorps) pathway, indicating that the mechanism is evolutionarily conserved.
PDK1 (Montrer PDPK1 Anticorps) has broad effects in hematopoiesis and is a critical factor for engraftment of both hematopoietic stem cells and multipotent progenitors upon transplantation to recipient mice.
our results offer significant insight into how PIK3CA (Montrer PIK3CA Anticorps) overexpression drives squamous cell carcinoma (HNSCC) invasion and metastasis, providing a rationale for targeting PI3K/PDK1 (Montrer PDPK1 Anticorps) and TGFb (Montrer TGFB1 Anticorps) signaling in advanced HNSCC patients with PIK3CA (Montrer PIK3CA Anticorps) amplification
PTEN (Montrer PTEN Anticorps) is required for stabilization of planar cell packing in the neural plate and for the formation of stable apical-basal microtubule arrays, while PDPK1 (Montrer PDPK1 Anticorps) is required for stabilization of apical junctions during epithelial morphogenesis.
results thus reveal an essential role for the PDK1 (Montrer PDPK1 Anticorps)-Akt (Montrer AKT1 Anticorps) pathway in the regulation of a key step of neuronal migration.
PDK1 (Montrer PDPK1 Anticorps) plays a pivotal role in regulating cardiac function and tumor metastasis by interfering with microenvironment.
Our data suggest that two arms of the glucose metabolism synergistically regulate the differential activation of macrophages. Our findings also highlight the central role of PDK1 (Montrer PDPK1 Anticorps) in this event via controlling glycolysis and glucose oxidation.
PDHK1 is expressed in Th17 cells, but not Th1 (Montrer HAND1 Anticorps) cells, and at low levels in Tregs, and inhibition or knockdown of PDHK1 selectively suppressed Th17 cells and increased Tregs.
The tyrosine phosphorylation enhances PDHK1 kinase activity by promoting ATP and PDC (Montrer PDC Anticorps) binding.
Pdk1 (Montrer PDPK1 Anticorps) enzyme is critical in conserving mitochondrial function by diverting metabolic intermediates to glycolysis
The pyruvate dehydrogenase (Montrer PDP Anticorps) kinases (PDKs) PDK1 and PDK3 (Montrer PDK3 Anticorps) are direct targets of KDM4A (Montrer KDM4A Anticorps) and E2F1 (Montrer E2F1 Anticorps) and modulate the switch between glycolytic metabolism and mitochondrial oxidation.
Ribociclib, in combination with GSK2334470 or the PI3Kalpha (Montrer PIK3CA Anticorps) inhibitor alpelisib, decreased xenograft tumor growth more potently than each drug alone. Taken together, our results highlight a role for the PI3K (Montrer PIK3CA Anticorps)-PDK1 signaling pathway in mediating acquired resistance to CDK4/6 (Montrer CDK4 Anticorps) inhibitors.
dicumarol potently inhibited the kinase activity of PDK1, shifted the glucose metabolism from aerobic glycolysis to oxidative phosphorylation, generated a higher level of reactive oxygen species (ROS (Montrer ROS1 Anticorps)), attenuated the mitochondrial membrane potential (MMP), induced apoptosis, and reduced cell viability in vitro.
our results offer significant insight into how PIK3CA (Montrer PIK3CA Anticorps) overexpression drives squamous cell carcinoma (HNSCC) invasion and metastasis, providing a rationale for targeting PI3K (Montrer PIK3CA Anticorps)/PDK1 and TGFb (Montrer TGFB1 Anticorps) signaling in advanced HNSCC patients with PIK3CA (Montrer PIK3CA Anticorps) amplification
miR (Montrer MLXIP Anticorps)-379 could function as a tumour-suppressing miRNA via targeting PDK1 in osteosarcoma.
These results also suggest that inhibition of HIF-1a (Montrer HIF1A Anticorps) with 2-MeOE2 sensitizes radioresistant melanoma cells 435R to X-ray irradiation through targeting the glycolysis that is regulated by PDK1
PDK1 is frequently upregulated in primary nasopharyngeal carcinoma and may serve as a prognostic marker.
A new function for PDK1 in metabolic reprogramming, which could be used to indicate the prognosis of Non small cell lung cancer and provide targeted therapeutic strategy for clinical treatment.
Our results demonstrated that down-regulation of SDHB (Montrer SDHB Anticorps) and up-regulation of PDK1 may be novel biomarkers for predicting advanced tumor progression and unfavorable prognosis in recurrent nasopharyngeal carcinoma patients
n the conditon of miR (Montrer MLXIP Anticorps)- 128b over-expression, we also observed spontaneous inactivation of the Akt (Montrer AKT1 Anticorps)/NF-kappaB (Montrer NFKB1 Anticorps) signalling, implying PDK1 was a potential regulator of this pathway. In conclusion, our study shed some novel light on miR (Montrer MLXIP Anticorps)-128b-PDK1/Akt (Montrer AKT1 Anticorps)/NF-kappaB (Montrer NFKB1 Anticorps) axis onGastric cancer (GC) progression
Dephosphorylation of PDK1 may be a molecular switch for enhancement of protein tyrosine phosphorylation and flagellar hyperactivation in boar spermatozoa.
Pyruvate dehydrogenase (PDH) is a mitochondrial multienzyme complex that catalyzes the oxidative decarboxylation of pyruvate and is one of the major enzymes responsible for the regulation of homeostasis of carbohydrate fuels in mammals. The enzymatic activity is regulated by a phosphorylation/dephosphorylation cycle. Phosphorylation of PDH by a specific pyruvate dehydrogenase kinase (PDK) results in inactivation.
pyruvate dehydrogenase kinase, isoenzyme 1
, pyruvate dehydrogenase kinase, isozyme 1
, pyruvate dehydrogenase [lipoamide] kinase isozyme 1, mitochondrial-like
, PDH kinase 1
, [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1, mitochondrial
, mitochondrial pyruvate dehydrogenase, lipoamide, kinase isoenzyme 1
, PDK p48
, pyruvate dehydrogenase kinase 1